$Jyong Biotech(MENS)$ This company looks fishy af, no recent finnacial fliings, their MCS-2 drug seems to have failed to show any statistically significant improvement in symptoms and they had to pool by ethnicity to get statistically sinificant results.
I might be wrong about all this, I can't find their raw trial data to see how large their pooled effect is and what their p-values were , but I have no idea how this company could possibly be worth 5 billion dollars.
Please, if anyone knows more about this let me know but I wouldn't touch this company with a 5ft pole.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments